Previous 1 2 3 4
"India is going to be a competitor in biotech research and not just a collaborator"
Dr Simon Best, the founder and present non-executive chairman of the Edinburgh-based Ardana Bioscience is also the chairman of Bio Industry Association (BIA) UK. He is also the non-executive chairman, Neuro3D, France and non-executive director, Avesthagen (India) and the Entelos Inc. (Wed, 26 Jul 2006 02:45:42 GMT)
Kreatech launches genome amplification kit
Kreatech Biotechnology BV launches "Genome-pULSe, arrayCGH Whole Genome Amplification and Labelling Kit" the latest addition to their product portfolio for arrayCGH analysis. (Wed, 26 Jul 2006 05:45:59 GMT)
Illumina to Webcast Presentation at Baird Oncology Conference
SAN DIEGO----July 26, 2006--Illumina, Inc. announced today that Jay Flatley, President and CEO, will be presenting at the upcoming Baird 2006 Focus on Oncology Conference in New York City, New York . (Wed, 26 Jul 2006 10:00:00 GMT)
Stratagene Provides Update on Invitrogen Lawsuit
LA JOLLA, Calif.----July 26, 2006--Stratagene Corporation , a developer, manufacturer and marketer of specialized life science research and diagnostic products, announced today that it was informed in the matter of Invitrogen Corporation vs. (Wed, 26 Jul 2006 10:30:00 GMT)
SRU Biosystems Awarded Fifth U.S. Patent
SRU Biosystems announced today that U.S. Patent 7,074,311 , entitled "Biosensor Electrophoresis" was issued to SRU Biosystems, Inc. on July 11, 2006. (Wed, 26 Jul 2006 11:00:00 GMT)
Applied Biosystems Innovation Enables Accurate, Quantitative Gene Expression Analysis of Very Small or Rare Samples
FOSTER CITY, Calif.----July 26, 2006--Applied Biosystems , an Applera Corporation business, today announced the launch of a commercial reagent mix that enables accurate, quantitative, real-time gene expression analysis on very small or rare samples. (Wed, 26 Jul 2006 11:00:00 GMT)
Simulation Of AZT Metabolism In Mitochondria In Computational Model
Researchers at the Virginia Bioinformatics Institute (VBI) at Virginia Tech have developed a computational model that allows scientists to better understand the metabolism and toxicity of the HIV/AIDS drug zidovudine (azidothymidine, AZT). [click link for full article] (Wed, 26 Jul 2006 11:03:09 GMT)
Reminder - Biosite to Conduct Second Quarter Results Conference Call
News) announces the following webcast: (Wed, 26 Jul 2006 11:45:00 GMT)
Illumina to Webcast Presentation at Baird Oncology Conference
Illumina, Inc. (NASDAQ:ILMN) announced today that Jay Flatley, President and CEO, will be presenting at the upcoming Baird 2006 Focus on Oncology Conference in New York City, New York (USA). Mr. Flatley's presentation will be webcast live beginning on or about 3:50 p.m. (Wed, 26 Jul 2006 12:08:56 GMT)
Genpathway Signs Worldwide Agreement With Affymetrix to Provide ChIP-on-Chip Assay Services for New GeneChip(R) Tiling
Genpathway announced today that it has entered into a worldwide services agreement with Affymetrix, Inc. whereby Genpathway will provide ChIP -on-Chip assays, services, and analysis to pharmaceutical, biotechnology, and academic/institutional researchers using the new Affymetrix GeneChip® Tiling Array Systems. (Wed, 26 Jul 2006 12:30:00 GMT)
The future of race-based medicine
Oakland, CA (July 25, 2006) - Health experts, researchers and opinion leaders from across the country will meet in Northern California for a national conference on genomics, health and race. (Wed, 26 Jul 2006 12:38:36 GMT)
Regulators give boost to two local biotechs
Two area biotech companies -- Advancis Pharmaceutical and Celera Genomics -- passed through regulatory mileposts, pushing their products into either the American or European markets. (Wed, 26 Jul 2006 13:07:26 GMT)
Stratagene Gets Unfavorable Jury Verdict
Stratagene Corp., a maker of life science research and testing products, said Wednesday a jury found that the company infringed a patent held by Invitrogen Corp., a maker of genomics research equipment. (Wed, 26 Jul 2006 13:18:19 GMT)
Stratagene Provides Update on Invitrogen Lawsuit; Competent Cells Patent At Issue
Stratagene Corporation (NASDAQ:STGN), a developer, manufacturer and marketer of specialized life science research and diagnostic products, announced today that it was informed in the matter of Invitrogen Corporation vs. (Wed, 26 Jul 2006 15:11:35 GMT)
Kreatech Biotechnology BV Launches The First Complete Kit For Whole Genome Amplification And Labeling For ArrayCGH
Kreatech Biotechnology BV announces the launch of the "Genome-pULSe, arrayCGH Whole Genome Amplification and Labeling Kit" the latest addition to their product portfolio for arrayCGH analysis (Wed, 26 Jul 2006 15:23:24 GMT)
Keeping Mind And Body Active Slows Alzheimer's
Researchers have uncovered the pathways behind the protection offered by environmental stimulation in Alzheimer's disease, further confirming that enhanced mental and physical activity slows neurological decline. The paper by Ambr-e et al. [click link for full article] (Wed, 26 Jul 2006 16:03:09 GMT)
Search results for «Careers»:
- Offer career development programs for latino employee and latino recruitment/retention programs for employers. - Features news articles and essays by scientists on how to find a job. Covers phd level occupations. Includes bioinformatics and Seattle biotechnology links. (Wed, 26 Jul 2006 16:37:38 GMT)
EMD Biosciences Launches the ProteoPlex(R) Human Angiogenesis Array
MADISON, Wis.----July 26, 2006--EMD Biosciences, Inc., a manufacturer of products for proteomics and disease pathway analysis, announces the launch of the ProteoPlex® Human Angiogenesis Array. (Wed, 26 Jul 2006 16:40:00 GMT)
In mice and men, cells age the same
We can dye gray hair, lift sagging skin or boost lost hearing, but no visit to the day spa would be able to hide a newly discovered genetic marker for the toll that time takes on our cells. "We've found something that is at the core of aging," said Stuart Kim, PhD, professor of developmental biology and of genetics at the School of Medicine. (Wed, 26 Jul 2006 18:02:05 GMT)
New animal model offers opportunity to develop therapies for lymphedema
Millions of cancer survivors face a lifetime of swelling and discomfort, caused by an untreatable buildup of fluid in their tissues. Medical school researchers have created an animal model for this complex condition, called lymphedema, taking the first steps toward understanding its behavior. (Wed, 26 Jul 2006 18:02:36 GMT)
Method Evolved for Recognition of Thombophilia (MERT): Clinical Predictive Genetic Test for Venous Thrombosis
Venous thrombosis (VT) is one of the leading causes of mortality and morbidity resulting in approximately 300,000 hospitalizations and 50,000 fatalities per year in the United States with an incidence of 141 per 100,000 African- Americans, 104 per 100,000 Caucasians and 21 per 100,000 Asian/Pacific Islanders. (Wed, 26 Jul 2006 18:04:57 GMT)
Biosite(R) Incorporated Announces Results for the Second Quarter of 2006
Biosite® Incorporated today reported financial results for the second quarter of 2006. (Wed, 26 Jul 2006 20:00:00 GMT)
Some happening courses of the season
Course selection at graduation level was once a game of luck. There was no option but to join BA, BSc, BCom or LLB. After three years into the course, one landed a job that one liked or not. (Wed, 26 Jul 2006 20:41:45 GMT)
/C O R R E C T I O N -- Biosite Incorporated/
News) Announces Results for the Second Quarter of 2006, issued earlier today by Biosite Incorporated over PR Newswire, we are advised by the company that in the first table the number in the "Other cardiovascular product sales" row, under the "Six months ended 6/30/05" column, should read "17,208" rather than "17,20." (Thu, 27 Jul 2006 00:01:00 GMT)
Luminex Corporation Reports Second Quarter 2006 Results
Luminex Corporation today announced financial results for the second quarter ended June 30, 2006. (Thu, 27 Jul 2006 00:11:10 GMT)
Shanghai Genomics forms collaboration with Centocor
Chinese biotech company Shanghai Genomics has entered in to a drug discovery project in collaboration with the US based biopharmaceutical company Centocor. (Thu, 27 Jul 2006 01:23:46 GMT)
Indo-US VAP developing candidate vaccines for priority diseases
The Indo-US Vaccine Action Programme (VAP) has led to the development of candidate vaccines for rotaviral diarrhoea, malaria, HIV, tuberculosis, cholera, respiratory syncytial virus (RSV) Group A Streptococcus (GAS) etc. VAP has decided to develop revised roadmap based on priority diseases prevalent in both countries. (Thu, 27 Jul 2006 02:45:52 GMT)
About Applera Corporation and Applied Biosystems
Applera Corporation consists of two operating groups. The Applied Biosystems Group serves the life science industry and research community by developing and marketing instrument-based systems, consumables, software, and services. (Thu, 27 Jul 2006 04:49:59 GMT)
Bio-IT Briefs
July 27, 2006 | A new screening approach can profile compounds in large chemical libraries more accurately and precisely than standard methods, speeding the production of data that can be used to probe biological activities and identify leads for drug discovery, the National Institutes of Health (NIH) Chemical Genomics Center, part of the NIH Roadmap for Medical Research’s Molecular Libraries and (Thu, 27 Jul 2006 06:45:32 GMT)
Murex Pharmaceuticals Licenses Ariadne’s Pathway Studio Software Solution To Be Utilized For Cancer Therapeutics
Ariadne Genomics, Inc. today announced that Murex Pharmaceuticals (Dallas, Texas) has licensed its Pathway Studio® software solution for the visualization and analysis of biological pathways and gene regulation networks. Murex will use Pathway Studio to develop computer-based models for the identification and validation of cancer targets. (PRWEB Jul 27, 2006) Trackback URI: (Thu, 27 Jul 2006 07:26:19 GMT)
Rosetta Genomics and Max Planck Society Enter Microrna Licensing Agreement
- (Thu, 27 Jul 2006 08:32:00 GMT)
Celera Genomics Reports Fourth Quarter and Fiscal 2006 Results
ROCKVILLE, Md.----July 27, 2006--Celera Genomics Group , an Applera Corporation business, today reported a net loss of $5.3 million, or $0.07 per share, for the fourth quarter of fiscal 2006 ended June 30, 2006, compared to a net loss of $16.4 million, or $0.22 per share, for the fourth quarter of fiscal 2005. (Thu, 27 Jul 2006 11:00:00 GMT)
Applied Biosystems Reports Fourth Quarter and Fiscal 2006 Results
FOSTER CITY, Calif.----July 27, 2006--Applied Biosystems Group : Q4 net revenues increased 9% to $523.1 million Q4 fully diluted GAAP EPS of $0.41, including gain on sale of property Q4 non-GAAP EPS was $0.35, excluding specified items (Thu, 27 Jul 2006 11:00:00 GMT)
Clinical Data's Cogenics Division Successfully Consolidates North Carolina Genomic Labs and Operations
NEWTON, Mass.----July 27, 2006--Clinical Data, Inc. , a worldwide leader in providing comprehensive molecular and pharmacogenomics services as well as clinical diagnostics to improve patient care, announced today that the Company has completed a key step in the consolidation of its North Carolina based genomic labs and offices it acquired as part of the Genaissance and Icoria acquisitions, (Thu, 27 Jul 2006 12:00:00 GMT)
fuse2006 Conference Continues to Attract World-Class Experts, Private & Public Leaders Focused on Accelerating
The fuse2006 conference continues to attract world-class experts as well as private and public leaders who are focused on making accelerated business growth in the Upstate New York region a reality. (Thu, 27 Jul 2006 12:00:00 GMT)
Murex Pharmaceuticals Licenses Ariadne’s Pathway Studio Software Solution To Be Utilized For Cancer Therapeutics
ROCKVILLE, Md. (PRWEB) July 27, 2006 -- Ariadne Genomics, Inc. (Thu, 27 Jul 2006 12:00:00 GMT)
(AFX UK Focus) 2006-07-27 12:43 GMT: Celera Genomics Q4 loss shrinks to 7 cents per share vs loss 22 cents
LONDON (AFX) - Celera Genomics Group, an Applera Corporation business, reported narrowing fourth-quarter losses of 5.3 mln usd or 7 cents per share, compared with a loss of 16.4 mln usd or 22 cents per share in the year-earlier period. (Thu, 27 Jul 2006 12:12:02 GMT)
Strategic Diagnostics to Report Second Quarter Results on August 3, 2006
NEWARK, Del.----July 27, 2006--Strategic Diagnostics Inc. a leading provider of biotechnology-based detection solutions for a broad range of food, water, agricultural, industrial, environmental and scientific applications, expects to release its second quarter results at approximately 4 p.m. (Thu, 27 Jul 2006 12:22:00 GMT)
UNCC Offshoot Opens Office Near New Biotech Hub: University Institute Aims to Stay on Top of Project in Kannapolis
By Adam Bell, The Charlotte Observer, N.C. Jul. 27--KANNAPOLIS -- The first science-related office near the North Carolina Research Campus occupies a modest two-room storefront with a computer, two tables and several chairs. (Thu, 27 Jul 2006 12:23:26 GMT)
Affymetrix to Webcast Presentation at Baird Oncology Conference
SANTA CLARA, Calif.----July 27, 2006--Affymetrix, Inc. today announced that Giulia C. Kennedy, Ph.D., Senior Director of Genomics Collaborations, will provide an overview of applications of Affymetrix technology in oncology research and clinical studies at the Baird 2006 Focus on Oncology Conference in New York, NY. (Thu, 27 Jul 2006 13:00:00 GMT)
University To Develop New Therapeutics For Cancer
A team of scientists at the University of Liverpool has secured the services of the National Biomanufacturing Centre (NBC) to develop and manufacture antibodies against a novel cancer antigen. (Thu, 27 Jul 2006 13:21:16 GMT)
Federal grant boosting OU genetics research
Ohio University is moving a step closer to the cutting edge of genetics research with a National Science Foundation-funded facility. (Thu, 27 Jul 2006 15:38:46 GMT)
Researchers 'Text Mine' The New York Times, Demonstrating Ease Of New Technology
Performing what a team of dedicated and bleary-eyed newspaper librarians would need months to do, scientists at UC Irvine have used an up-and-coming technology to complete in hours a complex topic analysis of 330,000 stories published primarily by The New York Times. (Thu, 27 Jul 2006 16:05:55 GMT)
Of Mac and Tux
Before last year, I have considered Apple's PowerPC-based platform as "a nice to have" platform for students. Most Computer Science and other IT-related degree courses are concentrating on the x86 architecture just like 20 years ago. (Thu, 27 Jul 2006 16:30:50 GMT)
Thermolabile Hydroxyl Protecting Groups and Methods of Use (2)
Synthetic oligonucleotides can be used in a wide variety of settings, which include gene therapy treatments, diagnostic and DNA sequencing microarray technology, and basic research. The NIH announces an improvement in oligonucleotide syntheses for potential application on glass microarrays. (Thu, 27 Jul 2006 18:04:17 GMT)
Clinical Data's Cogenics Division Successfully Consolidates North Carolina Genomic Labs and Operations
Clinical Data, Inc. (NASDAQ: CLDA), a worldwide (Thu, 27 Jul 2006 18:09:46 GMT)
Scientists Satisfied but Loyal Customers Remain Elusive for Many Suppliers
ARLINGTON, Va.----July 27, 2006--According to the findings of a recent survey of satisfaction and loyalty among over 1,700 life scientists, most leading life science suppliers enjoy customer satisfaction ratings of 70% or higher. (Thu, 27 Jul 2006 18:23:00 GMT)
Celera Genomics Group Narrows 4Q Loss
Biopharmaceutical and genetic technology company Celera Genomics Group, a unit of Applera Corp., said Thursday it narrowed its loss in the fourth quarter and the full fiscal year. (Thu, 27 Jul 2006 18:39:36 GMT)
Caprion Pharmaceuticals Withdraws Initial Public Offering
MONTREAL----July 27, 2006--Caprion Pharmaceuticals Inc. announced today that it has withdrawn its initial public offering due to adverse market conditions. (Thu, 27 Jul 2006 20:40:00 GMT)
CapitalBio Corporation to Offer Genotyping Services Using Affymetrix 500K Array in China
SANTA CLARA, Calif. & BEIJING----July 27, 2006--Affymetrix Inc., and CapitalBio Corporation, a leading life science company based in Beijing, P.R. China, announced today that CapitalBio has become a certified Affymetrix Service Provider and will begin offering genotyping services using the Affymetrix GeneChip® Human Mapping 500K Array Set. (Fri, 28 Jul 2006 00:00:00 GMT)
MDRF-ICMR Advanced Centre for Genomics to be launched
The MDRF-ICMR Advanced Centre for Genomics of Type two Diabetes, a joint project of the Chennai based Madras Diabetes Research Foundation (MDRF) and Indian Council for Medical Research (ICMR), will be launched by July 30. (Fri, 28 Jul 2006 02:45:53 GMT)
Commentary: The Personalized Medicine Revolution
By Stephen Prescott This spring, Celera Genomics announced it had developed a test to predict which patients with hepatitis C will eventually suffer liver scarring. (Fri, 28 Jul 2006 03:44:47 GMT)
Purdue Creates New Low-cost System To Detect Bacteria
Researchers at Purdue University have developed a new low-cost system that analyzes scattered laser light to quickly identify bacteria for applications in medicine, food processing and homeland security at one-tenth the cost of conventional technologies. (Fri, 28 Jul 2006 04:08:30 GMT)
Dr. John H. Abeles Joins CombiMatrix Scientific Advisory Board
NEWPORT BEACH, Calif.----July 28, 2006--Acacia Research Corporation announced today that John H. Abeles, M.D. has joined the Scientific Advisory Board of CombiMatrix. Dr. Abeles practiced medicine in London before joining the Pharmaceutical Industry as a Senior Medical Executive with Pfizer, Inc., Sterling Drug, and Revlon Health Care. (Fri, 28 Jul 2006 10:00:00 GMT)
Dr. John H. Abeles Joins CombiMatrix Scientific Advisory Board
Acacia Research Corporation (Nasdaq:CBMX)(Nasdaq:ACTG) announced today that John H. Abeles, M.D. has joined the Scientific Advisory Board of CombiMatrix. Dr. (Fri, 28 Jul 2006 13:25:14 GMT)
The Global Biotech/Pharmacogenomics/ Bioinformatics Product/Technology Sales In 2006 Report
DUBLIN, Ireland----July 28, 2006--Research and Markets has announced the addition of Biotechnology - Global Outlook 2006 to their offering. (Fri, 28 Jul 2006 13:52:00 GMT)
Unusual Mechanism Keeps Repair Protein Accurate
Cancer researchers have discovered that a recently identified protein critical for repairing damaged genes uses an unusual mechanism to keep its repairs accurate. The protein, called DNA polymerase lambda, is one of a group of proteins known as DNA polymerases that are vital for accurately making and repairing DNA. (Fri, 28 Jul 2006 16:09:37 GMT)
Heat Therapy For Cancer May Be Key To 'Lance Armstrong Effect'
Experts at Johns Hopkins have linked scientific evidence spanning more than 30 years to suggest an explanation for why testicular cancer patients like seven-time Tour de France winner Lance Armstrong survive far better than patients with other advanced cancers. (Fri, 28 Jul 2006 16:09:57 GMT)
Product: PipelineFX Demonstrates Qubic, Qube! At Siggraph 2006
PipelineFX announced that it will be showcasing the latest version of Qubic at SIGGRAPH 2006. Qubic 6 is a simple to use graphical user interface to the Qube! render farm management system that allows artists and administrators to easily manage their rendering and game build jobs. New features found in version 6 include a scriptable, extensible GUI, cleaner, more efficient task-based layouts (Fri, 28 Jul 2006 17:43:09 GMT)
Research units formed in biostatistics department at Wake Forest
Three new research groups have been established in the Wake Forest University School of Medicine's Department of Biostatistical Sciences, itself established earlier this year. (Fri, 28 Jul 2006 17:45:54 GMT)
Giving The Right Number Of "\sighs" Prevents Ventilation Induced Lung Injury
Ventilation therapy burst into the public consciousness more than 60 years ago with the "iron lung" and the polio epidemic. Mechanical ventilation has come a long way since then and is used today with patients who cannot breathe on their own because of trauma, lung injuries and chronic lung disease. [click link for full article] (Sat, 29 Jul 2006 04:15:34 GMT)
Of Mac and Tux
Before last year, I have considered Apple's PowerPC-based platform as "a nice to have" platform for students. Most Computer Science and other IT-related degree courses are concentrating on the x86 architecture just like 20 years ago. (Sat, 29 Jul 2006 16:36:32 GMT)
The Future Of Race-based Medicine Conference, August 18th And 19th, California
Health experts, researchers and opinion leaders from across the country will meet in Northern California for a national conference on genomics, health and race. The goal of the conference is to explore how genomics could potentially be used to customize medical care such as diet plans and medications to improve the health of minorities. [click link for full article] (Sat, 29 Jul 2006 23:15:35 GMT)
Follow Your Bliss, Yes, but Maybe Not Into a Stock Fund
Nascar race fans are certainly loyal, but should they be loyal to the StockCar Stocks Index fund? (Sun, 30 Jul 2006 00:44:51 GMT)
Follow Your Bliss, Yes, but Maybe Not Into a Stock Fund
Nascar race fans are certainly loyal, but should they be loyal to the StockCar Stocks Index fund? (Sun, 30 Jul 2006 00:45:01 GMT)
Laws of nature
* A century and a half ago, Charles Darwin sparked a scientific revolution. Now that revolution has become a culture war. But does the concept of “intelligent design” have validity as an alternative to evolution? Three new books look beyond the rhetoric. (Sun, 30 Jul 2006 03:12:03 GMT)
Rosetta Genomics signs agreement with Max Planck Society
The agreement will give the company access to patents covering hundreds of human microRNA sequences in diagnostic applications. (Sun, 30 Jul 2006 17:17:15 GMT)
Monday July 31, 2006
The Government's largest science company, AgResearch, says a new research arm it is setting up to focus on food will become its biggest. (Sun, 30 Jul 2006 17:26:24 GMT)
When Transgenes Wander, Should We Worry?
Just like their traditionally bred counterparts, transgenic crops have definitively been shown to crossbreed with crops or native plants growing nearby. In the July-September issue of the University of California's California Agriculture journal, a peer-reviewed review article documents widespread evidence that crop transgenes do, in fact, wander in the environment. But is this a cause for worry? (Sun, 30 Jul 2006 18:25:07 GMT)
Laws of nature
* A century and a half ago, Charles Darwin sparked a scientific revolution. Now that revolution has become a culture war. But does the concept of “intelligent design” have validity as an alternative to evolution? Three new books look beyond the rhetoric. (Sun, 30 Jul 2006 20:27:03 GMT)
Canadian VC closes age-related fund
A Montreal-based venture capital firm with a regional office in Weston has closed on a $65 million fund that will focus on diseases relating to aging. (Mon, 31 Jul 2006 04:42:27 GMT)
Sigma-Aldrich expands lentiviral shRNA gene family sets
Sigma-Aldrich leading $1.7 billion Life Science company and a member of The RNAi Consortium (TRC), announced the expansion of shRNA gene family sets in lentiviral format for direct use in gene silencing. (Mon, 31 Jul 2006 05:45:33 GMT)
Sen. Clinton Visits Buffalo
Senator Hillary Clinton will be in the Queen City today to host a New York Biotech Partnership Day at the Center for Excellence in Bioinformatics. (Mon, 31 Jul 2006 10:59:48 GMT)
DNAPrint Pharmaceuticals Completes the Development of an Analytical Method That Will Be Used for the Development of
DNAPrint Genomics, Inc. today announced that its subsidiary, DNAPrint Pharmaceuticals, Inc., has completed the development of the so-called "Western blot" method, an analytical procedure that identifies a protein according to its interaction with a specific antibody, a significant step in the development of its PT-401-based proprietary drug to treat anemia. (Mon, 31 Jul 2006 11:00:00 GMT)
Buffalo hosts biotech conference
U.S. Sen. Hillary Rodham Clinton is in Buffalo on Monday to host "New York Biotech Partnership Day," a conference focusing on new jobs in an emerging industry. (Mon, 31 Jul 2006 11:05:08 GMT)
Bio-IT Briefs
July 31, 2006 | Jim Greenwood , president and CEO of the Biotechnology Industry Organization (BIO), last week praised members of the Senate Small Business and Entrepreneurship Committee for supporting legislation that would restore Small Business Innovation Research (SBIR) grant eligibility to small biotech companies that are majority backed by private investment. (Mon, 31 Jul 2006 11:34:54 GMT)
Sequenom Selects Tata Consultancy Services to Develop Next Generation Framework for Life Science Software Applications
Sequenom, Inc. , a leading provider of genetic analysis solutions for epigenetic analysis, fine mapping, and molecular medicine, today announced that it has entered into an agreement with Tata Consultancy Services , a leading global technology services and consulting company, to develop software solutions that will support Sequenom's next generation of software tools and enable the delivery of (Mon, 31 Jul 2006 12:00:00 GMT)
Clinton to host Biotech Partnership Day
BUFFALO, N.Y. Senator Hillary Clinton will be in Buffalo today to host a New York Biotech Partnership Day at the Center for Excellence in Bioinformatics. (Mon, 31 Jul 2006 12:21:21 GMT)
GenoMed's First Horse Recovers Quickly from Presumed West Nile Virus Encephalitis
GenoMed , a Next Generation Disease Management company that uses genomics to solve diseases in as many species as possible, today announced that the first horse in its expanded trial for West Nile virus encephalitis recovered completely within 24 hours after starting GenoMed's treatment. (Mon, 31 Jul 2006 13:30:00 GMT)
Healtheuniverse Announces Strategic Expansion Plans in Singapore
Healtheuniverse Inc., a diversified biotechnology development firm specializing in the development and commercialization of patented biopharmaceutical and biomedical products announced today that it is completing its infrastructure development in Singapore with operations expected to begin in September 2006. Corporate headquarters for Asian operations and the research development laboratories (Mon, 31 Jul 2006 13:30:00 GMT)
For straight-shootin' tech talk, NPR has got the Gunn you want
EVERYBODY LOVES technology and bio-technology when they use it. Whether it is a high-definition television, wireless Internet service or a new drug to fight off an ailment, it's all cool to them. (Mon, 31 Jul 2006 13:38:38 GMT)
Clinton to host Biotech Partnership Day
BUFFALO, N.Y. Senator Hillary Clinton will be in Buffalo today to host a New York Biotech Partnership Day at the Center for Excellence in Bioinformatics. (Mon, 31 Jul 2006 13:39:27 GMT)
DNAPrint Pharmaceuticals Completes the Development of an Analytical Method That Will Be Used for the Development of
DNAPrint Genomics, Inc. (OTCBB: DNAG) today ann (Mon, 31 Jul 2006 15:31:01 GMT)
Monday July 31, 2006
The Government's largest science company, AgResearch, says a new research arm it is setting up to focus on food will become its biggest. (Mon, 31 Jul 2006 17:00:26 GMT)
Healtheuniverse Announces Strategic Expansion Plans in Singapore
Healtheuniverse Inc. (PINKSHEETS: HLUN), adiversified biotechnology development firm specializing in the developmentand commercialization of patented biopharmaceutical and biomedical productsannounced today that it is completing its infrastructure development inSingapore with operations expected to begin in September 2006. Corporateheadquarters for Asian operations and the research development (Mon, 31 Jul 2006 17:38:02 GMT)
Affymetrix Reports Second Quarter 2006 Results
SANTA CLARA, Calif.----July 31, 2006--Affymetrix, Inc., today reported its operating results for the second quarter of 2006. On a GAAP basis the Company reported net loss of approximately $10.1 million or $0.15 per diluted share in the second quarter of 2006, as compared to net income of $7.8 million or $0.12 per diluted share in the second quarter of 2005. (Mon, 31 Jul 2006 20:09:00 GMT)
Affymetrix shares slump after swinging to loss
SAN FRANCISCO (MarketWatch) -- Affymetrix Inc. shares slumped almost 9% in late trade Monday after the maker of genomics tools reported lower revenues and said it swung to a loss in the second quarter, hurt by a spike in costs. (Mon, 31 Jul 2006 21:10:24 GMT)
Affymetrix reports option irregularities, swings to $10.1M Q2 loss
Affymetrix Inc. said Monday it swung to a loss in the second quarter of about $10.1 million, or 15 cents a share, and reported that an internal review showed some dating problems on its stock option documentation. (Mon, 31 Jul 2006 21:27:15 GMT)
Penn Researchers Find Role For MicroRNAs In Angiogenesis
Researchers from the University of Pennsylvania School of Veterinary Medicine have identified how molecules of microRNA are responsible for the growth of blood vessels in a model for human colon cancer. The findings, which appear in the online version of Nature Genetics, suggest that these microRNAs might also be a good target for future therapeutics designed to slow the growth of cancer cells. (Mon, 31 Jul 2006 22:09:50 GMT)
Different Genes May Cause Autism In Boys And Girls
Different genes may be responsible for causing autism in boys than in girls, as well as the early onset form of the development disorder and the regression type of autism, according to a new study. It also provides new evidence that multiple genes contribute to autism. (Mon, 31 Jul 2006 22:10:13 GMT)
Previous 1 2 3 4
